Home/ Supplements/ Vitamin K/ Women's Heart Complex

Women's Heart Complex

product on market Softgel Capsule Doctor's Best Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

This formula contains CoQ10 and Vitamin K2, which have moderate evidence for supporting cardiovascular function and arterial health. Flaxseed oil and grape seed extract provide omega-3s and antioxidants to support vascular integrity. Overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Women's Heart Complex
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg (38% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)
300 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
100 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Sunflower Oil Yellow Beeswax Sunflower Lecithin Gelatin Glycerin Sorbitol Water, Purified Turmeric Olive Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Adult Use: Take 1 softgel daily preferably with a meal or as recommended by a nutritionally informed physician.

Warnings & Precautions

Warning: Not recommended for use during pregnancy. Consult your physician before using this product if you are pregnant, lactating, have a medical condition, or taking any anticoagulants.

Keep out of reach of children.

Formulation Notes

At Doctor's Best, we are unlocking the secret to a woman's heart. Our Women's Heart Complex is a unique blend featuring heart-energizing CoQ10, artery-supporting Vitamin K, blood vessel-maintaining Grapeseed antioxidants, and the nutritional powerhouse of Flaxseed Omega-3s, offering vital nutrients for overall cardiovascular and heart health.

Supports heart health & cellular energy Helps maintain blood vessel function Provides support for arterial health

Non-GMO Gluten Free Soy Free

Supports Cardiovascular Health

Additional Information

Store in a cool dry place.

Metadata

Product Details

UPC / SKU7 53950 00622 5
DSLD Entry Date2025-06-25
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID336254
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.